Next Article in Journal
Perforin Expression by CD4+ Regulatory T Cells Increases at Multiple Sclerosis Relapse: Sex Differences
Next Article in Special Issue
Role of Helicity on the Anticancer Mechanism of Action of Cationic-Helical Peptides
Previous Article in Journal
Pharmacological Classification and Activity Evaluation of Furan and Thiophene Amide Derivatives Applying Semi-Empirical ab initio Molecular Modeling Methods
Previous Article in Special Issue
CD146 Expression Correlates with Epithelial-Mesenchymal Transition Markers and a Poor Prognosis in Gastric Cancer
Int. J. Mol. Sci. 2012, 13(6), 6679-6697; doi:10.3390/ijms13066679

Intravascular Targets for Molecular Contrast-Enhanced Ultrasound Imaging

1,* , 1
1 MI Lab, Department of Circulation and Medical Imaging, Norwegian University of Science and Technology (NTNU), Trondheim N-7006, Norway 2 Department of Medical Technology, SINTEF Technology and Society, Trondheim N-7491, Norway
* Author to whom correspondence should be addressed.
Received: 19 April 2012 / Revised: 21 May 2012 / Accepted: 22 May 2012 / Published: 1 June 2012
(This article belongs to the Special Issue Advances in Molecular Oncology (special issue))
View Full-Text   |   Download PDF [1754 KB, uploaded 19 June 2014]   |   Browse Figures


Molecular targeting of contrast agents for ultrasound imaging is emerging as a new medical imaging modality. It combines advances in ultrasound technology with principles of molecular imaging, thereby allowing non-invasive assessment of biological processes in vivo. Preclinical studies have shown that microbubbles, which provide contrast during ultrasound imaging, can be targeted to specific molecular markers. These microbubbles accumulate in tissue with target (over) expression, thereby significantly increasing the ultrasound signal. This concept offers safe and low-cost imaging with high spatial resolution and sensitivity. It is therefore considered to have great potential in cancer imaging, and early-phase clinical trials are ongoing. In this review, we summarize the current literature on targets that have been successfully imaged in preclinical models using molecularly targeted ultrasound contrast agents. Based on preclinical experience, we discuss the potential clinical utility of targeted microbubbles.
Keywords: ultrasound imaging; targeted contrast agents; angiogenesis; molecular imaging; microbubbles; cancer ultrasound imaging; targeted contrast agents; angiogenesis; molecular imaging; microbubbles; cancer
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Share & Cite This Article

Further Mendeley | CiteULike
Export to BibTeX |
MDPI and ACS Style

Moestue, S.A.; Gribbestad, I.S.; Hansen, R. Intravascular Targets for Molecular Contrast-Enhanced Ultrasound Imaging. Int. J. Mol. Sci. 2012, 13, 6679-6697.

View more citation formats

Related Articles

Article Metrics

For more information on the journal, click here


Cited By

[Return to top]
Int. J. Mol. Sci. EISSN 1422-0067 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert